Short Interest in HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) Declines By 15.3%

[ad_1] <br><div id="articlecontent"> <p><img src="https://www.marketbeat.com/logos/hive-blockchain-technologies-ltd-logo.png?v=20221101141213" alt="HIVE Blockchain Technologies logo" title="HIVE Blockchain Technologies" class="companylogo"/>HIVE Blockchain Applied sciences Ltd. (<a target="_blank" href="https://www.marketbeat.com/stocks/NASDAQ/HIVE/" rel="noopener">NASDAQ:HIVE</a> - <a target="_blank" style="font-weight:normal;text-decoration:italic;color:green" href="https://report.stocknews.com/sign-up/ticker/?ticker=HIVE&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=HIVE&utm_content=text_link" rel="noopener">Get Rating</a>) was the recipient of a big decline in brief curiosity in November. As of November thirtieth, there was quick curiosity totalling 5,050,000 shares, a decline of 15.3% from the November fifteenth whole of 5,960,000 shares. Primarily based on a mean buying and selling quantity of 1,120,000 shares, the days-to-cover ratio is presently 4.5 days. Roughly 6.7% of the shares of the inventory are quick bought. </p><h2>HIVE Blockchain Applied sciences Buying and selling Up 1.6 %</h2><p><a target="_blank" href="https://www.marketbeat.com/stocks/NASDAQ/HIVE/options/" rel="noopener">NASDAQ HIVE</a> traded up $0.03 on Friday, hitting $1.89. 1,733,578 shares of the corporate had been exchanged, in comparison with its common quantity of 1,554,968. The corporate's 50 day shifting common worth is $2.57 and its 200-day shifting common worth is $3.61. The corporate has a debt-to-equity ratio of 0.11, a present ratio of three.75 and a fast ratio of three.75. The agency has a market capitalization of $156.92 million, a P/E ratio of -1.64 and a beta of two.11. HIVE Blockchain Applied sciences has a twelve month low of $1.77 and a twelve month excessive of $15.80. </p><h2>Wall Road Analyst Weigh In</h2><p>A number of equities analysis analysts have commented on the inventory. Canaccord Genuity Group boosted their worth goal on shares of HIVE Blockchain Applied sciences from $5.50 to $7.00 in a analysis report on Monday, August twenty ninth. Canaccord Genuity Group boosted their worth goal on shares of HIVE Blockchain Applied sciences from $5.50 to $7.00 and gave the inventory a "purchase" score in a analysis report on Monday, August twenty ninth. HC Wainwright dropped their worth goal on shares of HIVE Blockchain Applied sciences from $7.00 to $5.00 and set a "purchase" score on the inventory in a analysis report on Monday, December twelfth. TheStreet downgraded HIVE Blockchain Applied sciences from a "c" score to a "d+" score in a report on Thursday, September 1st. Lastly, <a target="_blank" style="font-weight:bold" href="https://report.stocknews.com/sign-up/ticker/?ticker=HIVE&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=HIVE&utm_content=text_link" rel="noopener">StockNews.com</a> upgraded HIVE Blockchain Applied sciences to a "promote" score in a report on Friday, October twenty first.</p><h2>Institutional Buying and selling of HIVE Blockchain Applied sciences</h2><p>Institutional buyers and hedge funds have just lately purchased and bought shares of the inventory. State Road Corp bought a brand new place in HIVE Blockchain Applied sciences in the course of the 2nd quarter valued at about $1,007,000. UBS Group AG grew its stake in HIVE Blockchain Applied sciences by 174.5% in the course of the third quarter. UBS Group AG now owns 17,829 shares of the corporate's inventory valued at $67,000 after buying an extra 11,333 shares within the final quarter. Tower Analysis Capital LLC TRC grew its stake in HIVE Blockchain Applied sciences by 154.6% in the course of the third quarter. Tower Analysis Capital LLC TRC now owns 15,072 shares of the corporate's inventory valued at $56,000 after buying an extra 9,153 shares within the final quarter. BlackRock Inc. grew its stake in HIVE Blockchain Applied sciences by 25.9% in the course of the third quarter. BlackRock Inc. now owns 82,303 shares of the corporate's inventory valued at $310,000 after buying an extra 16,951 shares within the final quarter. Lastly, Almanack Funding Companions LLC. bought a brand new place in HIVE Blockchain Applied sciences in the course of the third quarter valued at about $44,000. Institutional buyers and hedge funds personal 8.08% of the corporate's inventory. </p><h2 style="display:inline-block">About HIVE Blockchain Applied sciences</h2> (<a target="_blank" style="font-weight:normal;text-decoration:italic;color:green" href="https://report.stocknews.com/sign-up/ticker/?ticker=HIVE&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=HIVE&utm_content=text_link" rel="noopener">Get Rating</a>)<p>HIVE Blockchain Applied sciences Ltd. operates as a cryptocurrency mining firm in Canada, Sweden, and Iceland. It engages within the mining and sale of digital currencies, together with Ethereum, Ethereum Traditional, and Bitcoin. The corporate was previously often called Leeta Gold Corp. and altered its title to HIVE Blockchain Applied sciences Ltd.</p><h2>See Additionally</h2><p><em>This prompt information alert was generated by narrative science know-how and monetary information from MarketBeat with the intention to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat's editorial staff previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.</em></p><p>Earlier than you take into account HIVE Blockchain Applied sciences, you will wish to hear this.</p><p>MarketBeat retains observe of Wall Road's top-rated and finest performing analysis analysts and the shares they suggest to their shoppers every day. MarketBeat has recognized the <a target="_blank" href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&RegistrationCode=ArticlePage-ShouldYouInvest" rel="noopener">five stocks</a> that prime analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on... and HIVE Blockchain Applied sciences wasn't on the listing.</p><p>Whereas HIVE Blockchain Applied sciences presently has a "Purchase" score amongst analysts, top-rated analysts consider these 5 shares are higher buys.</p><p><a target="_blank" class="sbbutton" style="text-decoration:none" href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&RegistrationCode=ArticlePage-ShouldYouInvest" rel="noopener">View The Five Stocks Here <span class="mr-3 mb-icon icon-arrow" aria-hidden="true"/></a></p> </div> <br>[ad_2] <br><a href="https://news.google.com/__i/rss/rd/articles/CBMiVGh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1oaXZlLW9wdGlvbnMtZGF0YS1yZXBvcnQtMjAyMi0xMi0yL9IBAA?oc=5">Source link </a>